|Bid||266.50 x 243000|
|Ask||267.90 x 260500|
|Day's Range||266.20 - 268.20|
|52 Week Range||218.30 - 273.00|
|PE Ratio (TTM)||23.79|
|Earnings Date||Jul 27, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Roche Holding AG is seeking a partner with experimental drugs that might help repair the damage caused to the nervous system by multiple sclerosis -- considered a key step in managing the debilitating ...
Human antibody discovery has come a long way in the last two decades, with contributions from transgenic mice and phage display. Author reviews the data on their success, speculates of why the former has outperformed, closing with thoughts on the future of antibody discovery
Maybe this new breed of cancer drugs won't see skyrocketing sales growth.